NCT00896792 is a EARLY_PHASE1 clinical trial of counseling intervention in Hematopoietic/Lymphoid Cancer, sponsored by Mayo Clinic.

Who is sponsoring NCT00896792?

NCT00896792 is sponsored by Mayo Clinic.

What drugs are being tested in NCT00896792?

Interventions in NCT00896792: counseling intervention, questionnaire administration, survey administration, end-of-life treatment/management, psychosocial assessment and care.

What condition does NCT00896792 study?

NCT00896792 studies Hematopoietic/Lymphoid Cancer, Unspecified Adult Solid Tumor, Protocol Specific.

Is NCT00896792 still recruiting?

NCT00896792 is currently completed. Last updated 9 October 2018.

Last reviewed 2018-10-09 · How we verify

NCT00896792

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers

Completed EARLY_PHASE1 Last updated 9 October 2018

What this trial tests

EARLY_PHASE1 trial testing counseling intervention in Hematopoietic/Lymphoid Cancer in 26 participants. Completed in 17 March 2015.

Timeline

10 October 2008

Primary endpoint
20 November 2009

17 March 2015

Quick facts

Lead sponsor	Mayo Clinic
Phase	EARLY_PHASE1
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Primary purpose	other
Enrollment	26
Start date	10 October 2008
Primary completion	20 November 2009
Estimated completion	17 March 2015
Sites	1 location across United States

Drugs / interventions tested

counseling intervention
questionnaire administration
survey administration
end-of-life treatment/management
psychosocial assessment and care

Conditions studied

Hematopoietic/Lymphoid Cancer — all drugs for Hematopoietic/Lymphoid Cancer →
Unspecified Adult Solid Tumor, Protocol Specific — all drugs for Unspecified Adult Solid Tumor, Protocol Specific →

Sponsor

Mayo Clinic

Who can join

Adults 18 to 120, any sex, with Hematopoietic/Lymphoid Cancer or Unspecified Adult Solid Tumor, Protocol Specific. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

RATIONALE: Gathering information about patients with terminal metastatic cancer may help doctors learn more about the effectiveness of a nurse practitioner hospice program. It is not yet known whether a nurse practitioner program helps increase patients' length of stay in hospice. PURPOSE: This randomized research study is evaluating a nurse practitioner hospice program for patients with terminal metastatic cancer and their families or caregivers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A nurse practitioner directed intervention improves the quality of life of patients with metastatic cancer: results of a randomized pilot study.
Dyar S, Lesperance M, Shannon R, Sloan J, et al · · 2012 · cited 76× · PMID 22559906 · DOI 10.1089/jpm.2012.0014

Verify or expand the search:

Other trials of counseling intervention

Trials testing the same drug.

NCT01941784 — Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoi · NA · completed
NCT02129569 — Psychoeducational and Behavioral Strategies in Reducing Distress and Anxiety in Patients With Multiple Myeloma and Their · NA · completed
NCT02465541 — Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer S · NA · completed
NCT01824745 — Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors · NA · active not recruiting
NCT01450020 — Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors · NA · active not recruiting

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00896792 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 9 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00896792.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing